Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 7886
  • 7887
  • 7888
  • …
  • ›
  • »

2025-10-14

The Travel Agency Reveals the True Story Behind Its Viral Cannabis Carrier Pigeon Campaign

2025-10-14

Eupraxia Pharmaceuticals Inc. (EPRX) is a Great Momentum Stock: Should You Buy?

2025-10-14

Are You Looking for a Top Momentum Pick? Why Galiano Gold (GAU) is a Great Choice

2025-10-14

Eupraxia Pharmaceuticals Inc. (EPRX) Upgraded to Buy: Here′s Why

2025-10-14

Christian Dior : Improvement in trends in the third quarter of 2025

2025-10-14

Xencor slides amid plans for early-stage trial data for kidney cancer drug

2025-10-14

Loncor agrees on $261M sale to China′s Chengtun

2025-10-14

Ekinops 2025 nine-month revenue: 79.5 m€ Evolution of Ekinops′ corporate governance

2025-10-14

Optomed marks its fifth year at the ACVO Annual Conference by displaying the Aurora IQ

2025-10-14

EQS-News: The world's largest technology fair, Gitex Global, is coming to Southeastern Europe, hosted by Belgrade

2025-10-14

Why OFG Bancorp (OFG) is a Great Dividend Stock Right Now

2025-10-14

TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals

  • «
  • ‹
  • …
  • 7886
  • 7887
  • 7888
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies